Zobrazeno 1 - 9
of 9
pro vyhledávání: '"James W. Lillard Jr."'
Publikováno v:
Frontiers in Bioscience-Scholar, Vol 12, Iss 1, Pp 137-160 (2020)
Breast cancer (BrCa) is the most commonly diagnosed cancer and the second leading cause of cancer-related death in women. Alarming increases in the cases quests for more effective treatment of BrCa. As most chemotherapeutic drugs are associated with
Externí odkaz:
https://doaj.org/article/f9787d781a804188b72d78c8a59a32b4
Autor:
Olayinka O. Adebayo, Eric B. Dammer, Courtney D. Dill, Adeyinka O. Adebayo, Saheed O. Oseni, Ti’ara L. Griffen, Adaugo Q. Ohandjo, Fengxia Yan, Sanjay Jain, Benjamin G. Barwick, Rajesh Singh, Lawrence H. Boise, James W. Lillard, Jr.
Publikováno v:
Cancers; Volume 14; Issue 9; Pages: 2228
The molecular mechanisms underlying chemoresistance in some newly diagnosed multiple myeloma (MM) patients receiving standard therapies (lenalidomide, bortezomib, and dexamethasone) are poorly understood. Identifying clinically relevant gene networks
Publikováno v:
The Journal of Immunology. 182:98.4-98.4
Prostate cancer (PCa) is the second leading cause of cancer morbidity and mortality among men in the United States. Mortality is not due to primary tumor growth but rather from complications caused by metastasis to vital organs. It is well known that
Autor:
Christelle P El-Haibi, Paul R Johnson, Praveen K Sharma, Jill Suttles, Shailesh Singh, James W Lillard, Jr.
Publikováno v:
The Journal of Immunology. 182:98.5-98.5
We have previously shown that CXCR5 is significantly expressed by the prostate cancer (PCa) tissue than compared to high grade prostatic intraepithelial neoplasia and benign prostatic hyperplasia. We have also demonstrated PCa cell lines significantl
Publikováno v:
The Journal of Immunology. 182:42.7-42.7
In our study, we determined the utility of cisplatin-loaded biodegradable XPclad nanoparticles coated with polycaprolactone-polyethylene glycol copolymers conjugated to folate. We hypothesized that these 28 ± 5 nm sized particles would enhance the t
Publikováno v:
The Journal of Immunology. 182:98.3-98.3
Metastasis of breast cancer (BrCa) cells involves organ-specific homing for migration, invasion, adhesion, and survival at secondary sites. Chemokines, such as stromal cell-derived factor-1 (SDF-1; CXCL12) and interferon-inducible T cell α-chemoattr
Publikováno v:
The Journal of Immunology. 182:98.2-98.2
Chemokines and their receptors have been implicated in organ-specific homing of metastatic breast cancer (BrCa) cells. Stromal cell-derived factor-1 (SDF-1; CXCL12), a homeostatic chemokine, has been suggested to promote BrCa progression. Interferon-
Autor:
Praveen K Sharma, Rajesh Singh, John W Eaton, James W Lillard, Jr., Kristian R Novakovic, William E Grizzle, Shailesh Singh
Publikováno v:
The Journal of Immunology. 182:98.1-98.1
Despite of current advancement in treatment and management of prostate cancer (PCa); it is still remaining the second leading cause of cancer-related deaths among men in the US. Current chemotherapeutic regimens provided palliative benefit but relati
Autor:
Courtney D. Dill, Eric B. Dammer, Ti'ara L. Griffen, Nicholas T. Seyfried, James W. Lillard, Jr.
Publikováno v:
iScience, Vol 24, Iss 5, Pp 102451- (2021)
Summary: We aimed to identify triple-negative breast cancer (TNBC) drivers that regulate survival time as predictive signatures that improve TNBC prognostication. Breast cancer (BrCa) transcriptomic tumor biopsies were analyzed, identifying network c
Externí odkaz:
https://doaj.org/article/d1754814fdaf4fc894b95c476afd8f35